Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Strata Critical Medical, Inc.SRTA · Entity 5512 | Director · Co-CEO and General Counsel | September 24, 2026 | September 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Strata Critical Medical, Inc.
Report date September 24, 2026 · Filed September 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stock, $0.0001 par value per shareSEC Table I · non-derivative | Direct | 2,153,678 |
Ending reported balance
After 2026-09-24 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-24 · Grant · Acquired 177,858 · Balance 2,244,475 F1: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on August 29, 2026 Row 2 · 2026-09-24 · Tax withholding · Disposed 90,797 · Balance 2,153,678 F2: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on August 29, 2026
F2: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 24, 2026 Filed Sep 25, 2026 20:12 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 90,797 | $5.27 | $478,500.19 |
DisclosureSEC source: 0001628280-26-063577 · wk-form4_1790367150.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,153,678 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs Read SEC document |
| September 24, 2026 Filed Sep 25, 2026 20:12 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 177,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-063577 · wk-form4_1790367150.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,244,475 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on August 29, 2026 Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:26 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 29,730 | $5.31 | $157,866.30 |
DisclosureSEC source: 0001628280-26-061363 · wk-form4_1789072000.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,066,617 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| July 31, 2026 Filed Aug 3, 2026 20:06 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 212,309 | $5.09 | $1,080,652.81 |
DisclosureSEC source: 0001628280-26-051811 · wk-form4_1785787559.xml · nonDerivative · entry 3 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,096,347 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| July 30, 2026 Filed Aug 3, 2026 20:06 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 206,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-051811 · wk-form4_1785787559.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,308,656 F2 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025. Read SEC document |
| July 30, 2026 Filed Aug 3, 2026 20:06 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 208,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-051811 · wk-form4_1785787559.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,101,703 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:05 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 29,730 | $5.87 | $174,515.10 |
DisclosureSEC source: 0001628280-26-042180 · wk-form4_1781121946.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,892,774 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 08, 2026 Filed Jun 18, 2026 20:10 UTC Amendment | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 29,730 | $5.87 | $174,515.10 |
DisclosureSEC source: 0001628280-26-044280 · wk-form4a_1781813409.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,892,774 F1 · kind: On June 10, 2026, the reporting person filed a Form 4 (the "Original Form") which inadvertently used the "S" code in Column 3 of Table I in connection with the disposal of certain shares of the Issuer's Class A common stock (the "Shares") on June 8, 2026. The Shares were in fact withheld by the Issuer to satisfy tax withholding obligations in connection a vesting event in a transaction approved in accordance with Rule 16b-3 of the Securities Exchange Act of 1934, as amended. Footnote 1 to the Original Form correctly described the transaction as "shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units." Accordingly, the reporting person is hereby amending the Original Form to correctly show the "F" code in Column 3 of Table I. The information set forth in the Original Form was correct in all other respects. F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 21:46 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 321,750 | $4.92 | $1,583,010.00 |
DisclosureSEC source: 0001628280-26-027656 · wk-form4_1777326379.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,922,504 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 21:46 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 630,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-027656 · wk-form4_1777326379.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,244,254 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 21:29 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 29,372 | $4.54 | $133,348.88 |
DisclosureSEC source: 0001628280-26-016560 · wk-form4_1773178155.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,613,990 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:22 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 276,960 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001628280-26-000460 · wk-form4_1767648138.xml · derivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A common stock, $0.0001 par value per share · 276,960 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:22 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 276,960 | $0.18 | $49,852.80 |
DisclosureSEC source: 0001628280-26-000460 · wk-form4_1767648138.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,643,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:06 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 34,018 | $4.38 | $148,998.84 |
DisclosureSEC source: 0001628280-25-056756 · wk-form4_1765573572.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,366,402 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 21:20 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 27,778 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001628280-25-051621 · wk-form4_1762982408.xml · derivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,960 Underlying: Class A common stock, $0.0001 par value per share · 27,778 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 21:20 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 27,778 | $0.18 | $5,000.04 |
DisclosureSEC source: 0001628280-25-051621 · wk-form4_1762982408.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,400,420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:52 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 106,659 | $5.03 | $536,494.77 |
DisclosureSEC source: 0001628280-25-049659 · wk-form4_1762379538.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,372,642 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| October 31, 2025 Filed Nov 5, 2025 21:52 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 208,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-049659 · wk-form4_1762379538.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,479,301 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024. Read SEC document |
| October 22, 2025 Filed Oct 23, 2025 20:06 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 55,556 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001628280-25-046085 · wk-form4_1761249984.xml · derivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 304,738 Underlying: Class A common stock, $0.0001 par value per share · 55,556 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 22, 2025 Filed Oct 23, 2025 20:06 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 55,556 | $0.18 | $10,000.08 |
DisclosureSEC source: 0001628280-25-046085 · wk-form4_1761249984.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,270,372 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 10, 2025 Filed Oct 14, 2025 20:27 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 55,555 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001628280-25-044977 · wk-form4_1760473634.xml · derivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 360,294 Underlying: Class A common stock, $0.0001 par value per share · 55,555 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 10, 2025 Filed Oct 14, 2025 20:27 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 55,555 | $0.18 | $9,999.90 |
DisclosureSEC source: 0001628280-25-044977 · wk-form4_1760473634.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,214,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 21:04 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 34,018 | $4.00 | $136,072.00 |
DisclosureSEC source: 0001779128-25-000108 · wk-form4_1757711088.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · Director · Co-CEO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,159,261 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 07, 2025 Filed Aug 7, 2025 21:35 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 23,945 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-25-000086 · wk-form4_1754602537.xml · derivative · entry 4 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 415,849 Underlying: Class A common stock, $0.0001 par value per share · 23,945 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2025 Filed Aug 7, 2025 21:35 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 23,945 | $0.18 | $4,310.10 |
DisclosureSEC source: 0001779128-25-000086 · wk-form4_1754602537.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,193,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2025 Filed Aug 7, 2025 21:35 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 20,500 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-25-000086 · wk-form4_1754602537.xml · derivative · entry 3 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 439,794 Underlying: Class A common stock, $0.0001 par value per share · 20,500 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2025 Filed Aug 7, 2025 21:35 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 20,500 | $0.18 | $3,690.00 |
DisclosureSEC source: 0001779128-25-000086 · wk-form4_1754602537.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,169,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2025 Filed Aug 5, 2025 22:14 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 47,995 | $4.94 | $237,133.70 |
DisclosureSEC source: 0001779128-25-000077 · wk-form4_1754432079.xml · nonDerivative · entry 3 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,148,834 F3 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.94 to $4.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 22:14 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 81,071 | $3.99 | $323,473.29 |
DisclosureSEC source: 0001779128-25-000077 · wk-form4_1754432079.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,196,829 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 22:14 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 160,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-25-000077 · wk-form4_1754432079.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,277,900 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:21 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 34,018 | $3.80 | $129,268.40 |
DisclosureSEC source: 0001779128-25-000050 · wk-form4_1749676871.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,117,186 F3 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 21:21 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 100,000 | $4.08 | $407,530.00 |
DisclosureSEC source: 0001779128-25-000050 · wk-form4_1749676871.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,151,204 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.96 to $4.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 28, 2025 Filed Mar 28, 2025 20:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 27,777 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-25-000025 · wk-form4_1743192135.xml · derivative · entry 4 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 460,294 Underlying: Class A common stock, $0.0001 par value per share · 27,777 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2025 Filed Mar 28, 2025 20:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 27,777 | $0.18 | $4,999.86 |
DisclosureSEC source: 0001779128-25-000025 · wk-form4_1743192135.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,251,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 20:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 27,779 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-25-000025 · wk-form4_1743192135.xml · derivative · entry 3 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 488,071 Underlying: Class A common stock, $0.0001 par value per share · 27,779 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 20:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 27,779 | $0.18 | $5,000.22 |
DisclosureSEC source: 0001779128-25-000025 · wk-form4_1743192135.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,223,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:23 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 34,291 | $3.12 | $106,987.92 |
DisclosureSEC source: 0001779128-25-000020 · wk-form4_1742243018.xml · nonDerivative · entry 3 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,195,648 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:23 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 132,326 | $3.12 | $412,857.12 |
DisclosureSEC source: 0001779128-25-000020 · wk-form4_1742243018.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,229,939 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:23 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 257,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-25-000020 · wk-form4_1742243018.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,362,265 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 22:42 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-25-000004 · wk-form4_1736548951.xml · derivative · entry 8 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 515,850 Underlying: Class A common stock, $0.0001 par value per share · 50,000 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 22:42 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 50,000 | $0.18 | $9,000.00 |
DisclosureSEC source: 0001779128-25-000004 · wk-form4_1736548951.xml · nonDerivative · entry 4 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,105,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 22:42 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 27,716 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-25-000004 · wk-form4_1736548951.xml · derivative · entry 7 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 565,850 Underlying: Class A common stock, $0.0001 par value per share · 27,716 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 22:42 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 16,020 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-25-000004 · wk-form4_1736548951.xml · derivative · entry 6 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A common stock, $0.0001 par value per share · 16,020 shares Expires 2029-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 22:42 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 6,264 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-25-000004 · wk-form4_1736548951.xml · derivative · entry 5 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A common stock, $0.0001 par value per share · 6,264 shares Expires 2028-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 22:42 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 27,716 | $0.18 | $4,988.88 |
DisclosureSEC source: 0001779128-25-000004 · wk-form4_1736548951.xml · nonDerivative · entry 3 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,055,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 22:42 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 16,020 | $0.18 | $2,883.60 |
DisclosureSEC source: 0001779128-25-000004 · wk-form4_1736548951.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,027,406 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 22:42 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 6,264 | $0.18 | $1,127.52 |
DisclosureSEC source: 0001779128-25-000004 · wk-form4_1736548951.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,011,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2024 Filed Dec 11, 2024 22:37 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 34,018 | $4.72 | $160,564.96 |
DisclosureSEC source: 0001779128-24-000154 · wk-form4_1733956659.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,005,122 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 22:37 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 22,486 | $5.01 | $112,699.83 |
DisclosureSEC source: 0001779128-24-000154 · wk-form4_1733956659.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,039,140 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| November 29, 2024 Filed Nov 29, 2024 23:25 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 22,135 | $5.02 | $111,186.32 |
DisclosureSEC source: 0001779128-24-000136 · wk-form4_1732922714.xml · nonDerivative · entry 3 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,061,626 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.085, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.